ZBIO (Zenas BioPharma) FFO


ZBIO Zenas BioPharma Inc ZBIO
12 GF Score
Price $25.79
! 1 Warning Sign
View Full Analysis

What is Zenas BioPharma FFO?

FFO (Funds from operations) only applies to REITs.

ZBIO
12GF Score
Zenas BioPharma Inc ZBIO
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zenas BioPharma Business Description

Address 852 Winter Street, Suite 250, Waltham, MA, USA, 02451
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. The Company manages its operations on a consolidated basis as a single reportable segment focused on the research, development and commercialization of transformative immunology-based therapies.
12GF Score

Get the complete analysis for ZBIO

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.79
Price